UNAIDS is holding its first round of virtual consultations to develop its 2016–2021 Strategy. From 23 March to 2 April, the consultation process will be open to everyone to share information, ideas and experiences on how to accelerate rights-based, evidence-informed action to Fast-Track the AIDS response.
26 March 2015 | UNAIDS
Officials from NIH and the city of Washington, D.C., launched a clinical trial to examine whether primary care physicians and other health care providers, such as nurse practitioners and physician assistants, can use a new antiviral therapy as effectively as specialist physicians to treat people with hepatitis C virus (HCV) infection. The trial, which will involve 600 adult D.C. residents infected with HCV alone or co-infected with HCV and HIV, also will examine the long-term effects of the treatment.
09 March 2015 | EurekAlert
The scientific evidence is clear. As a result of extraordinary advances in biomedical research, we now have the tools we need to end the HIV epidemic in the United States. Or do we? According to, "When We Know Better, We Do Better: State of HIV/AIDS Science and Treatment Literacy," a recently released national report by the Black AIDS Institute and others, the missing link to ending the AIDS epidemic in the U.S. is increasing the science and treatment literacy among the non-medical HIV/AIDS workforce.
04 February 2015 | News Medical
Some states let doctors give antibiotics to a patient and to a nonpatient sexual partner. The strategy has been shown to lower rates of chlamydia and gonorrhoea, but remains underused because most states do not cover the medications’ cost and many doctors are uncomfortable treating patients they have not evaluated.
03 February 2015 | New York Times
The Zimbabwean government is with effect from this month switching all people on HIV treatment to a new one of one tablet per day from the previous three pills to make it easier for patients not to default on taking medication. The new single tablet has a combination of three drugs (Tenofovir/Lamivudine/Efavirenz TLE), a departure from the previous complicated treatment of three different tablets namely Tenofovir, Lovovidine and Nevirapine (TLN).
07 January 2015 | NewZimbabwe.com
Why are South African men reluctant to test for HIV, to start and stay on ART, and to join support groups? Is it that health services are not men-friendly? Is it an idea of masculinity that mandates men to be stoic, to hide pain as a weakness and not to talk about their feelings? What defines the relationship of men to health services and how can it be improved? In this video by Davison Mudzingwa, experts and activists like Thamela, analyze the factors that drive men’s gendered vulnerability to HIV in South Africa and suggest ways to reduce it.
23 December 2014 | IPS
Home- and community-based HIV testing and counselling services can achieve high participation uptake in rural Africa but reach different populations within a community and should be provided, depending on the groups that are being targeted, according to new research published in PLOS Medicine.
17 December 2014 | Medical News Today
Diagnosing HIV and other infectious diseases presents unique challenges in remote locations that lack electric power, refrigeration, and appropriately trained health care staff. To address these issues, researchers have developed a low-cost, electricity-free device capable of detecting the DNA of infectious pathogens, including HIV-1.
10 December 2014 | Science Daily
The CDC has reframed the HIV treatment cascade figures to highlight the various reasons why only 30 percent of Americans have a fully suppressed virus.
03 December 2014 | POZ
While we have made progress in HIV prevention and care, only 30% of all people living with HIV have achieved viral suppression. If people are in HIV medical care, however, 76% of people achieve viral suppression. Getting and keeping people in HIV medical care saves lives.
26 November 2014 | CDC Vital Signs